Remanded (sent back)
The Board remands the claims for further medical development to determine whether the Veteran's papillary renal cell carcinoma is active or in remission, and if there has been cessation of treatment.
The deciding factor: The January 2025 VA examiner's findings were found inadequate due to lack of supporting evidence and potential contradictions with other medical records.
- Claimed conditions
- papillary renal cell carcinoma, kidney cysts
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- November 21, 2025
- Citation
- A25101539
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.